"Designing Growth Strategies is in our DNA"
Figure 1: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2027
Figure 2: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Disease Indication, 2019 & 2027
Figure 3: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Arthritis, 2016-2027
Figure 4: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Migraine, 2016-2027
Figure 5: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Ophthalmic Diseases, 2016-2027
Figure 6: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Others, 2016-2027
Figure 7: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Route of Administration, 2019 & 2027
Figure 8: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Oral, 2016-2027
Figure 9: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Parenteral, 2016-2027
Figure 10: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Distribution Channel, 2019 & 2027
Figure 11: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Hospital Pharmacy, 2016-2027
Figure 12: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Retail Pharmacy, 2016-2027
Figure 13: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast (US$ Bn), by Online Pharmacy, 2016-2027
Figure 14: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Region, 2019 & 2027
Figure 15: North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Disease Indication, 2019 & 2027
Figure 16: North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Disease Indication, 2019
Figure 17: North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Route of Administration, 2019 & 2027
Figure 18: North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Route of Administration, 2019
Figure 19: North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Distribution Channel, 2019 & 2027
Figure 20: North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Distribution Channel, 2019
Figure 21: North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), By Country, 2019 & 2027
Figure 22: North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), By Country, 2019
Figure 23: Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Disease Indication, 2019 & 2027
Figure 24: Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Disease Indication, 2019
Figure 25: Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Route of Administration, 2019 & 2027
Figure 26: Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Route of Administration, 2019
Figure 27: Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Distribution Channel, 2019 & 2027
Figure 28: Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Distribution Channel, 2019
Figure 29: Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027
Figure 30: Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), By Country/ Sub-region, 2019
Figure 31: Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Disease Indication, 2019 & 2027
Figure 32: Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Disease Indication, 2019
Figure 33: Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Route of Administration, 2019 & 2027
Figure 34: Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Route of Administration, 2019
Figure 35: Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Distribution Channel, 2019 & 2027
Figure 36: Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Distribution Channel, 2019
Figure 37: Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027
Figure 38: Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), By Country/ Sub-region, 2019
Figure 39: Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Disease Indication, 2019 & 2027
Figure 40: Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Disease Indication, 2019
Figure 41: Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Route of Administration, 2019 & 2027
Figure 42: Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Route of Administration, 2019
Figure 43: Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Distribution Channel, 2019 & 2027
Figure 44: Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Distribution Channel, 2019
Figure 45: Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027
Figure 46: Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), By Country/ Sub-region, 2019
Figure 47: Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Disease Indication, 2019 & 2027
Figure 48: Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Disease Indication, 2019
Figure 49: Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Route of Administration, 2019 & 2027
Figure 50: Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Route of Administration, 2019
Figure 51: Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), by Distribution Channel, 2019 & 2027
Figure 52: Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), by Distribution Channel, 2019
Figure 53: Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027
Figure 54: Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Value Share (%), By Country/ Sub-region, 2019
Figure 55: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (%), By Company, 2019
Table 1: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016–2027
Table 2: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016–2027
Table 3: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027
Table 4: Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Region, 2016-2027
Table 5: North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027
Table 6: North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027
Table 7: North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027
Table 8: North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, By Country, 2016-2027
Table 9: Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027
Table 10: Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027
Table 11: Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027
Table 12: Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027
Table 13: Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027
Table 14: Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027
Table 15: Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027
Table 16: Asia Pacific Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027
Table 17: Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027
Table 18: Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027
Table 19: Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027
Table 20: Latin America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027
Table 21: Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027
Table 22: Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027
Table 23: Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027
Table 24: Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027